(Q24289307)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Gene expression profiling predicts clinical outcome of breast cancer

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Molecular portraits of human breast tumours

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Gene expression profiling: does it add predictive accuracy to clinical characteristics in cancer prognosis?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Concordance among gene-expression-based predictors for breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Microarray data analysis: from disarray to consolidation and consensus

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Roadmap for developing and validating therapeutically relevant genomic classifiers

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

REporting recommendations for tumour MARKer prognostic studies (REMARK)

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Individual response to treatment: is it a valid assumption?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

"Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Optimal gene expression analysis by microarrays

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

What do we mean by validating a prognostic model?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360153

Is cross-validation valid for small-sample microarray classification?

27 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603673

Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603673

False discovery rate, sensitivity and sample size for microarray studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603673

Bias as a threat to the validity of cancer molecular-marker research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603673

Microarrays and clinical investigations

21 January 2018

1 reference

12 December 2020

Prediction of cancer outcome with microarrays: a multiple random validation strategy

1 reference

12 December 2020

Validation of Microarray Data by Quantitative Reverse-Transcriptase Polymerase Chain Reaction

1 reference

12 December 2020

Gene expression profiling for individualized breast cancer chemotherapy: success or not?

1 reference

12 December 2020

Rules of evidence for cancer molecular-marker discovery and validation

1 reference

12 December 2020

Microarrays and molecular research: noise discovery?

1 reference

12 December 2020

Road map to metastasis

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6603673

1 reference

Dimensions Publication ID

3521696

1037541535

0 references

3521696

1 reference

1 reference

1 reference